December 10, 2024
Meet us at the British Pharmacological Society’s (BPS) Pharmacology 2024 conference and learn how opnMe fosters academic innovation by sharing free molecules as well as providing collaborative funding opportunities via defined crowdsourcing questions.
Below, you can access the posters that we present at this annual BPS event from December 10 to 12, 2024 in Harrogate.
Poster 1: opnMe.com: The open innovation portal of Boehringer Ingelheim
Abstract
opnMe.com fosters an environment that accelerates independent innovation and discovery, by providing scientists with access to selected, well-characterized, best-in-class molecules. It also invites scientists to propose innovative solutions for precisely-formulated scientific questions for a chance to obtain research funding if selected. Last but not least, opnMe.com provides an opportunity for high-caliber talents to pitch their scientific approaches for well-defined research questions to conduct their research at one of our discovery research sites. Initiatives such as opnMe foster an environment that accelerates innovation and discovery. A wide spectrum of research fields benefitted from this approach and may translate into novel therapeutic options.
Poster 2: Fostering independent academic research and forging new academic/pharma partnerships: Case studies and outcomes from Boehringer Ingelheim's opnMe platform
Abstract
From December 2017 until November 2024, Boehringer Ingelheim’s open innovation portal opnMe has received >2,400 collaborative research proposals and enabled >140 partnerships with scientists worldwide. In this poster, we present opnMe’s impact in fostering novel insights by highlighting research examples covering independent use of molecules, as well as collaborative research partnerships.
Subscribe to our newsletter to stay updated as we add new opportunities to opnMe.com.
About opnMe:
opnMe.com, the open innovation portal of Boehringer Ingelheim, fosters science and collaboration initiatives in areas of high unmet medical need. As part of our first pillar, the “Molecules to Order”, we share well-characterized tool compounds free of charge with no IP strings attached. These are complemented by “Molecules for Collaboration” where we offer access to unprecedented, often unpublished molecules, together with an attractive funding package. Interested scientists are invited to submit testable research hypotheses with these assets in novel diseases or combinations. With our “opn2EXPERTS” program, we enlist scientific advice on key biologic issues to fuel further drug discovery and deliver novel solutions that benefit unmet patient needs. Our opn2TALENTS PostDoc grants provide an opportunity for high-caliber talents to pitch their scientific approaches for well-defined research questions to conduct their research at one of our discovery research sites.